Literature DB >> 3771779

Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection.

B R Murphy, D W Alling, M H Snyder, E E Walsh, G A Prince, R M Chanock, V G Hemming, W J Rodriguez, H W Kim, B S Graham.   

Abstract

The serum antibody response of 50 infants and children infected with respiratory syncytial virus (RSV) was determined by a glycoprotein-specific enzyme-linked immunosorbent assay, and the effects of age and preexisting antibody titer at the time of RSV infection on response to the G and F glycoproteins of RSV were examined. The immune response to the G and F glycoproteins was assessed with anti-human immunoglobulin A to permit measurement of the response of young infants in the presence of maternally derived immunoglobulin G. The findings suggested that age primarily affects the response to the F glycoprotein and that preexisting antibody titer affects the response to the G glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771779      PMCID: PMC269059          DOI: 10.1128/jcm.24.5.894-898.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children.

Authors:  R M CHANOCK; H W KIM; A J VARGOSKO; A DELEVA; K M JOHNSON; C CUMMING; R H PARROTT
Journal:  JAMA       Date:  1961-05-27       Impact factor: 56.272

2.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection.

Authors:  H W Kim; J O Arrobio; C D Brandt; B C Jeffries; G Pyles; J L Reid; R M Chanock; R H Parrott
Journal:  Am J Epidemiol       Date:  1973-09       Impact factor: 4.897

3.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

4.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

5.  Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.

Authors:  E E Walsh; J Hruska
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

6.  Secretory antibody response to respiratory syncytial virus infection.

Authors:  T N Kaul; R C Welliver; D T Wong; R A Udwadia; K Riddlesberger; P L Ogra
Journal:  Am J Dis Child       Date:  1981-11

7.  An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test.

Authors:  H V Coates; D W Alling; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

8.  The immunologic response to infection with respiratory syncytial virus in infants.

Authors:  K McIntosh; H B Masters; I Orr; R K Chao; R M Barkin
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

9.  Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection.

Authors:  L S Richardson; R H Yolken; R B Belshe; E Camargo; H W Kim; R M Chanock
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

10.  The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses.

Authors:  R C Welliver; T N Kaul; T I Putnam; M Sun; K Riddlesberger; P L Ogra
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

View more
  61 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

Review 2.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

3.  Antibody response to respiratory syncytial virus infection in children <18 months old.

Authors:  Susanna Esposito; Elisa Scarselli; Mara Lelii; Alessia Scala; Alessandra Vitelli; Stefania Capone; Marco Fornili; Elia Biganzoli; Annalisa Orenti; Alfredo Nicosia; Riccardo Cortese; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 4.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

5.  The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.

Authors:  Youri Lee; Eun-Ju Ko; Ki-Hye Kim; Young-Tae Lee; Hye Suk Hwang; Yu-Jin Jung; Subbiah Jeeva; Young-Man Kwon; Baik Lin Seong; Sang Moo Kang
Journal:  Antiviral Res       Date:  2019-05-28       Impact factor: 5.970

Review 6.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection.

Authors:  R C Welliver; M Sun; S W Hildreth; R Arumugham; P L Ogra
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

8.  Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.

Authors:  Eileen Goodwin; Morgan S A Gilman; Daniel Wrapp; Man Chen; Joan O Ngwuta; Syed M Moin; Patricia Bai; Arvind Sivasubramanian; Ruth I Connor; Peter F Wright; Barney S Graham; Jason S McLellan; Laura M Walker
Journal:  Immunity       Date:  2018-02-03       Impact factor: 31.745

9.  Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses.

Authors:  Richard Singleton; Nathalie Etchart; Sam Hou; Lisa Hyland
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay.

Authors:  M J Meddens; P Herbrink; J Lindeman; W C van Dijk
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.